189 related articles for article (PubMed ID: 20384750)
21. Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss.
Ahluwalia GS
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S73-6. PubMed ID: 24326568
[TBL] [Abstract][Full Text] [Related]
22. Long-term utility and durability of the therapeutic effects of bimatoprost 0.03% for eyelash augmentation in healthy Asian subjects.
Kwon O; Kim JY; Paik SH; Jeon HC; Jung YJ; Lee Y; Baek JH; Chun JH; Lee WS; Lee JY; Rogers JD; Halstead M; Eun HC
Dermatology; 2014; 229(3):222-9. PubMed ID: 25228046
[TBL] [Abstract][Full Text] [Related]
23. Unilateral trichomegaly induced by bimatoprost ophthalmic solution.
Hempstead N; Hempstead RW
J Drugs Dermatol; 2004; 3(5):571-2. PubMed ID: 15552614
[TBL] [Abstract][Full Text] [Related]
24. Successful use of bimatoprost in the treatment of alopecia of the eyelashes.
Zaheri S; Hughes B
Clin Exp Dermatol; 2010 Jun; 35(4):e161-2. PubMed ID: 19925481
[No Abstract] [Full Text] [Related]
25. Eyelash preservation during chemotherapy and topical prostaglandin therapy.
Moroi SE
Arch Intern Med; 2010 Jul; 170(14):1269-70. PubMed ID: 20660849
[No Abstract] [Full Text] [Related]
26. A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis.
Yoelin SG; Fagien S; Cox SE; Davis PG; Campo A; Caulkins CA; Gallagher CJ
Dermatol Surg; 2014 Oct; 40(10):1118-24. PubMed ID: 25229783
[TBL] [Abstract][Full Text] [Related]
27. Topical bimatoprost for the treatment of eyebrow hypotrichosis.
Schweiger ES; Pinchover L; Bernstein RM
J Drugs Dermatol; 2012 Jan; 11(1):106-8. PubMed ID: 22206085
[TBL] [Abstract][Full Text] [Related]
28. Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes.
Wester ST; Lee WW; Shi W
Ophthalmology; 2010 May; 117(5):1024-31. PubMed ID: 20163864
[TBL] [Abstract][Full Text] [Related]
29. Bimatoprost solution 0·03% topical application to the eyelid margin for the treatment of eyelash hypotrichosis.
Arujuna NR; Topham EJ; Atkinson LR; George SM; Derrick EK; Farrant PB
Br J Dermatol; 2016 Jun; 174(6):1416-7. PubMed ID: 26873623
[No Abstract] [Full Text] [Related]
30. Hypertrichosis of the eyelashes caused by bimatoprost.
Tosti A; Pazzaglia M; Voudouris S; Tosti G
J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S149-50. PubMed ID: 15577756
[TBL] [Abstract][Full Text] [Related]
31. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
Hart J; Shafranov G
Am J Ophthalmol; 2004 Apr; 137(4):756-7. PubMed ID: 15059720
[TBL] [Abstract][Full Text] [Related]
32. Revisiting the Safety of Prostaglandin Analog Eyelash Growth Products.
Steinsapir KD; Steinsapir SMG
Dermatol Surg; 2021 May; 47(5):658-665. PubMed ID: 33625141
[TBL] [Abstract][Full Text] [Related]
33. The biodisposition and hypertrichotic effects of bimatoprost in mouse skin.
Woodward DF; Tang ES; Attar M; Wang JW
Exp Dermatol; 2013 Feb; 22(2):145-8. PubMed ID: 23278986
[TBL] [Abstract][Full Text] [Related]
34. Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.
Aydin S; Işikligil I; Tekşen YA; Kir E
Cutan Ocul Toxicol; 2010 Sep; 29(3):212-6. PubMed ID: 20670089
[TBL] [Abstract][Full Text] [Related]
35. Management of hypotrichosis of the eyelashes: Focus on bimatoprost.
Fagien S
Clin Cosmet Investig Dermatol; 2010 Apr; 3():39-48. PubMed ID: 21437058
[TBL] [Abstract][Full Text] [Related]
36. Treatment of eyebrow hypotrichosis using bimatoprost: a randomized, double-blind, vehicle-controlled pilot study.
Beer KR; Julius H; Dunn M; Wilson F
Dermatol Surg; 2013 Jul; 39(7):1079-87. PubMed ID: 23617229
[TBL] [Abstract][Full Text] [Related]
37. Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.
Centofanti M; Oddone F; Chimenti S; Tanga L; Citarella L; Manni G
Am J Ophthalmol; 2006 Dec; 142(6):1059-60. PubMed ID: 17157592
[TBL] [Abstract][Full Text] [Related]
38. Iris heterochromia and unilateral eyelash hypertrichosis.
Rao RC; Ballard TN; Chen TC
JAMA; 2015 May; 313(19):1967-8. PubMed ID: 25988467
[TBL] [Abstract][Full Text] [Related]
39. Bimatoprost in the treatment of eyelash hypotrichosis.
Law SK
Clin Ophthalmol; 2010 Apr; 4():349-58. PubMed ID: 20463804
[TBL] [Abstract][Full Text] [Related]
40. Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost.
Herane MI; Urbina F
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):644-5. PubMed ID: 15324422
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
